Literature DB >> 19858092

Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling.

Jiaming Wen1, Xianzhen Jiang, Yingbo Dai, Yujin Zhang, Yuxin Tang, Hong Sun, Tiejuan Mi, Prasad V Phatarpekar, Rodney E Kellems, Michael R Blackburn, Yang Xia.   

Abstract

Priapism is a condition of persistent penile erection in the absence of sexual excitation. Of men with sickle cell disease (SCD), 40% display priapism. The disorder is a dangerous and urgent condition, given its association with penile fibrosis and eventual erectile dysfunction. Current strategies to prevent its progression are poor because of a lack of fundamental understanding of the molecular mechanisms for penile fibrosis in priapism. Here we demonstrate that increased adenosine is a novel causative factor contributing to penile fibrosis in two independent animal models of priapism, adenosine deaminase (ADA)-deficient mice and SCD transgenic mice. An important finding is that chronic reduction of adenosine by ADA enzyme therapy successfully attenuated penile fibrosis in both mouse models, indicating an essential role of increased adenosine in penile fibrosis and a novel therapeutic possibility for this serious complication. Subsequently, we identified that both mice models share a similar fibrotic gene expression profile in penile tissue (including procollagen I, TGF-beta(1), and plasminogen activator inhibitor-1 mRNA), suggesting that they share similar signaling pathways for progression to penile fibrosis. Thus, in an effort to decipher specific cell types and underlying mechanism responsible for adenosine-mediated penile fibrosis, we purified corpus cavernosal fibroblast cells (CCFCs), the major cell type involved in this process, from wild-type mice. Quantitative RT-PCR showed that the major receptor expressed in these cells is the adenosine receptor A(2B)R. Based on this fact, we further purified CCFCs from A(2B)R-deficient mice and demonstrated that A(2B)R is essential for excess adenosine-mediated penile fibrosis. Finally, we revealed that TGF-beta functions downstream of the A(2B)R to increase CCFC collagen secretion and proliferation. Overall, our studies identify an essential role of increased adenosine in the pathogenesis of penile fibrosis via A(2B)R signaling and offer a potential target for prevention and treatment of penile fibrosis, a dangerous complication seen in priapism.-Wen, J., Jiang, X., Dai, Y., Zhang, Y., Tang, Y., Sun, H., Mi, T., Phatarpekar, P. V., Kellems, R. E., Blackburn, M. R., Xia, Y. Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A(2B) adenosine receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19858092      PMCID: PMC2830141          DOI: 10.1096/fj.09-144147

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  40 in total

1.  Knockout-transgenic mouse model of sickle cell disease.

Authors:  T M Ryan; D J Ciavatta; T M Townes
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

2.  Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice.

Authors:  J L Chunn; H W Young; S K Banerjee; G N Colasurdo; M R Blackburn
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

3.  Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis.

Authors:  Edwin S L Chan; Maria Carmen Montesinos; Patricia Fernandez; Avani Desai; David L Delano; Herman Yee; Allison B Reiss; Michael H Pillinger; Jiang-Fan Chen; Michael A Schwarzschild; Scott L Friedman; Bruce N Cronstein
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

4.  Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat.

Authors:  Monica G Ferrini; Hugo H Davila; Istvan Kovanecz; Sandra P Sanchez; Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Urology       Date:  2006-08       Impact factor: 2.649

5.  Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease.

Authors:  Hugo H Davila; Thomas R Magee; Dolores Vernet; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  Biol Reprod       Date:  2004-07-07       Impact factor: 4.285

6.  Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling.

Authors:  Tiejuan Mi; Shahrzad Abbasi; Hong Zhang; Karen Uray; Janci L Chunn; Ling Wei Xia; Jose G Molina; Norman W Weisbrodt; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

7.  Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway.

Authors:  Mário Angelo Claudino; Carla Fernanda Franco-Penteado; Marcus Alexandre Finzi Corat; Ana Paula Gimenes; Luiz Augusto Correa Passos; Edson Antunes; Fernando Ferreira Costa
Journal:  J Sex Med       Date:  2009-06-02       Impact factor: 3.802

8.  Adenosine 2B receptors (A(2B)AR) on enteric neurons regulate murine distal colonic motility.

Authors:  Bindu P Chandrasekharan; Vasantha L Kolachala; Guillaume Dalmasso; Didier Merlin; Katya Ravid; Shanthi V Sitaraman; Shanthi Srinivasan
Journal:  FASEB J       Date:  2009-04-08       Impact factor: 5.191

9.  Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection.

Authors:  Istvan Kovanecz; Amarnath Rambhatla; Monica G Ferrini; Dolores Vernet; Sandra Sanchez; Jacob Rajfer; Nestor Gonzalez-Cadavid
Journal:  BJU Int       Date:  2007-09-20       Impact factor: 5.588

Review 10.  Pathophysiology of priapism: dysregulatory erection physiology thesis.

Authors:  Arthur L Burnett
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

View more
  38 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  A2B adenosine receptor-mediated induction of IL-6 promotes CKD.

Authors:  Yingbo Dai; Weiru Zhang; Jiaming Wen; Yujin Zhang; Rodney E Kellems; Yang Xia
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

Review 3.  Stuttering priapism: insights into pathogenesis and management.

Authors:  Belinda F Morrison; Arthur L Burnett
Journal:  Curr Urol Rep       Date:  2012-08       Impact factor: 3.092

Review 4.  Beneficial and detrimental role of adenosine signaling in diseases and therapy.

Authors:  Hong Liu; Yang Xia
Journal:  J Appl Physiol (1985)       Date:  2015-08-27

Review 5.  Metabolomic and molecular insights into sickle cell disease and innovative therapies.

Authors:  Morayo G Adebiyi; Jeanne M Manalo; Yang Xia
Journal:  Blood Adv       Date:  2019-04-23

6.  Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis.

Authors:  Biljana Musicki; Tongyun Liu; Sena F Sezen; Arthur L Burnett
Journal:  J Sex Med       Date:  2012-05-23       Impact factor: 3.802

Review 7.  Purinergic regulation of the immune system.

Authors:  Caglar Cekic; Joel Linden
Journal:  Nat Rev Immunol       Date:  2016-03       Impact factor: 53.106

Review 8.  The role of adenosine signaling in sickle cell therapeutics.

Authors:  Joshua J Field; David G Nathan; Joel Linden
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

9.  Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension.

Authors:  Shraddha Nayak; Md Abdul H Khan; Tina C Wan; Hong Pei; Joel Linden; Melinda R Dwinell; Aron M Geurts; John D Imig; John A Auchampach
Journal:  Purinergic Signal       Date:  2015-09-18       Impact factor: 3.765

Review 10.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.